CD19 and acute lymphoblastic leukemia: Moreover, all our patients were diagnosed with ALL relapse and underwent transplantation after January 2015 and, consequently, modern ex vivo graft manipulation strategies such as αβ T-cell/CD19+ and CD45RA+ depletion were the most frequently applied (16).